Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Bayerl

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|August 15, 2021
Identification of invariant chain CD74 as a functional receptor of tissue inhibitor of metalloproteinases-1 (TIMP-1)Benjamin Schoeps, Celina Eckfeld, Laura Flüter, et al.
The Journal of Cell Biology|January 11, 2023
TIMP-1 is a novel ligand of Amyloid Precursor Protein and triggers a proinflammatory phenotype in human monocytesCelina Eckfeld, Benjamin Schoeps, Daniel Häußler, et al.
BMC Cancer|January 22, 2020
IL-1-conferred gene expression pattern in ERα<sup>+</sup> BCa and AR<sup>+</sup> PCa cells is intrinsic to ERα<sup>-</sup> BCa and AR<sup>-</sup> PCa cells and promotes cell survivalAfshan F Nawas, Mohammed Kanchwala, Shayna E Thomas-Jardin, et al.
European Journal of Immunology|January 9, 2023
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methodsFelix Bayerl, David A Bejarano, Giulia Bertacchi, et al.
Cell Reports|November 14, 2024
Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunityAnna-Marie Pedde, Hyunu Kim, Sainitin Donakonda, et al.
Cancer Cell|July 14, 2023
A distinct stimulatory cDC1 subpopulation amplifies CD8<sup>+</sup> T cell responses in tumors for protective anti-cancer immunityPhilippa Meiser, Moritz A Knolle, Anna Hirschberger, et al.
Immunity|June 14, 2023
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesFelix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Nature|November 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Nature|April 24, 2024
PGE<sub>2</sub> limits effector expansion of tumour-infiltrating stem-like CD8<sup>+</sup> T cellsSebastian B Lacher, Janina Dörr, Gustavo P de Almeida, et al.
Nature|March 25, 2021
Auto-aggressive CXCR6<sup>+</sup> CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|August 15, 2021
Identification of invariant chain CD74 as a functional receptor of tissue inhibitor of metalloproteinases-1 (TIMP-1)Benjamin Schoeps, Celina Eckfeld, Laura Flüter, et al.
The Journal of Cell Biology|January 11, 2023
TIMP-1 is a novel ligand of Amyloid Precursor Protein and triggers a proinflammatory phenotype in human monocytesCelina Eckfeld, Benjamin Schoeps, Daniel Häußler, et al.
BMC Cancer|January 22, 2020
IL-1-conferred gene expression pattern in ERα<sup>+</sup> BCa and AR<sup>+</sup> PCa cells is intrinsic to ERα<sup>-</sup> BCa and AR<sup>-</sup> PCa cells and promotes cell survivalAfshan F Nawas, Mohammed Kanchwala, Shayna E Thomas-Jardin, et al.
European Journal of Immunology|January 9, 2023
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methodsFelix Bayerl, David A Bejarano, Giulia Bertacchi, et al.
Cell Reports|November 14, 2024
Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunityAnna-Marie Pedde, Hyunu Kim, Sainitin Donakonda, et al.
Cancer Cell|July 14, 2023
A distinct stimulatory cDC1 subpopulation amplifies CD8<sup>+</sup> T cell responses in tumors for protective anti-cancer immunityPhilippa Meiser, Moritz A Knolle, Anna Hirschberger, et al.
Immunity|June 14, 2023
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesFelix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Nature|November 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Nature|April 24, 2024
PGE<sub>2</sub> limits effector expansion of tumour-infiltrating stem-like CD8<sup>+</sup> T cellsSebastian B Lacher, Janina Dörr, Gustavo P de Almeida, et al.
Nature|March 25, 2021
Auto-aggressive CXCR6<sup>+</sup> CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.
Pageof 2